Hopefully we see this momentum continue from here.
Clear, concise communications; Continual market engagement; and Phase 2a Peach designed and starting Q3 has to be minimum steps. Once safety and tolerability are established doing some additional studies in areas of high dengue rates and high mortality rates would also be good but I think their focus will be on getting 2a started.
- Forums
- ASX - By Stock
- Ann: Third cohort dosed in ISLA-101 Single Ascending Dose study
Hopefully we see this momentum continue from here. Clear,...
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ILA (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.373M |
Open | High | Low | Value | Volume |
5.6¢ | 5.6¢ | 5.6¢ | $1.521K | 27.16K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 5.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.5¢ | 83969 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.055 |
1 | 37735 | 0.053 |
1 | 211000 | 0.052 |
1 | 100000 | 0.051 |
2 | 340000 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.065 | 83969 | 1 |
0.070 | 133322 | 1 |
0.080 | 100000 | 1 |
0.160 | 60000 | 1 |
0.000 | 0 | 0 |
Last trade - 10.50am 06/05/2024 (20 minute delay) ? |
|
|||||
Last
5.6¢ |
  |
Change
0.000 ( 1.82 %) |
|||
Open | High | Low | Volume | ||
5.7¢ | 5.7¢ | 5.6¢ | 87836 | ||
Last updated 10.50am 06/05/2024 ? |
Featured News
ILA (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online